Skip to main content
Top
Published in: Heart and Vessels 5/2021

01-05-2021 | Arterial Diseases | Original Article

Functional assessment of intermediate coronary artery stenosis with 4-Fr catheters

Authors: Kazutaka Nogi, Tsunenari Soeda, Masahiko Hara, Hajime Iwama, Nozomi Toyokawa, Satoshi Sakai, Hiroki Yano, Atsushi Iwai, Yukihiro Hashimoto, Hajime Fujimoto, Megumi Suzuki, Takehito Nakai, Naofumi Doi, Yoshihiko Saito

Published in: Heart and Vessels | Issue 5/2021

Login to get access

Abstract

The 4-Fr catheter system is not recommended for invasive functional assessment of coronary artery stenosis, because it tends to distort the aortic waveform. This study aimed to identify the incidence of aortic waveform distortion and a feasible method for correct diagnosis of coronary artery stenosis with a 4-Fr catheter. We retrospectively investigated 178 lesions with intermediate coronary artery stenosis. Non-hyperemic distal coronary artery pressure (Pd) and aortic pressure (Pa) were measured with a 4-Fr diagnostic or 6-Fr guiding catheter before and after saline flush. The mean Pd/mean Pa (Pd/Pa) and instantaneous wave-free ratio (iFR) were calculated before and after flushing. We compared the effect of flushing on the changes in Pd/Pa and iFR between the 4-Fr diagnostic and 6-Fr guiding catheters. Using the 4-Fr diagnostic catheter, there was a significant decrease in incidence of aortic waveform distortion from 42.0% (47 lesions) before flushing to 1.8% (2 lesions) after flushing (p < 0.001); the incidence was only 3.0% before saline flush and decreased to 0% after saline flush when using the 6-Fr guiding catheter. The presence of aortic waveform distortion influenced the iFR when the 4-Fr system was used. Functional measurements with the 4-Fr diagnostic catheter require adequate saline flush to remove the influence of aortic waveform distortion.
Literature
1.
go back to reference Pijls NH, van Schaardenburgh P, Manoharan G, Boersma E, Bech JW, Veer M, Bär F, Hoorntje J, Koolen J, Wijns W, de Bruyne B (2007) Percutaneous coronary intervention of functionally nonsignificant stenosis: 5-year follow-up of the DEFER study. J Am Coll Cardiol 49:2105–2211CrossRef Pijls NH, van Schaardenburgh P, Manoharan G, Boersma E, Bech JW, Veer M, Bär F, Hoorntje J, Koolen J, Wijns W, de Bruyne B (2007) Percutaneous coronary intervention of functionally nonsignificant stenosis: 5-year follow-up of the DEFER study. J Am Coll Cardiol 49:2105–2211CrossRef
2.
go back to reference Tonino PA, De Bruyne B, Pijls NH, Siebert U, Ikeno F, Veer M, Klauss V, Manoharan G, Engstrøm T, Oldroyd KG, Ver Lee PN, MacCarthy PA, Fearon WF, FAME Study Investigators (2009) Fractional flow reserve versus angiography for guiding percutaneous coronary intervention. N Engl J Med 360:213–224CrossRef Tonino PA, De Bruyne B, Pijls NH, Siebert U, Ikeno F, Veer M, Klauss V, Manoharan G, Engstrøm T, Oldroyd KG, Ver Lee PN, MacCarthy PA, Fearon WF, FAME Study Investigators (2009) Fractional flow reserve versus angiography for guiding percutaneous coronary intervention. N Engl J Med 360:213–224CrossRef
3.
go back to reference De Bruyne B, Pijls NH, Kalesan B, Barbato E, Tonino PA, Piroth Z, Jagic N, Möbius-Winkler S, Rioufol G, Witt N, Kala P, MacCarthy P, Engström T, Oldroyd KG, Mavromatis K, Manoharan G, Verlee P, Frobert O, Curzen N, Johnson JB, Jüni P, Fearon WF, FAME 2 Trial Investigators (2012) Fractional flow reserve-guided PCI versus medical therapy in stable coronary disease. N Engl J Med 367:991–1001CrossRef De Bruyne B, Pijls NH, Kalesan B, Barbato E, Tonino PA, Piroth Z, Jagic N, Möbius-Winkler S, Rioufol G, Witt N, Kala P, MacCarthy P, Engström T, Oldroyd KG, Mavromatis K, Manoharan G, Verlee P, Frobert O, Curzen N, Johnson JB, Jüni P, Fearon WF, FAME 2 Trial Investigators (2012) Fractional flow reserve-guided PCI versus medical therapy in stable coronary disease. N Engl J Med 367:991–1001CrossRef
4.
go back to reference Patel MR, Calhoon JH, Dehmer GJ, Grantham JA, Maddox TM, Maron DJ, Smith PK (2017) ACC/AATS/AHA/ASE/ASNC/SCAI/SCCT/STS 2017 appropriate use criteria for coronary revascularization in patients with stable ischemic heart disease: a report of the American College of Cardiology Appropriate Use Criteria Task Force, American Association for Thoracic Surgery, American Heart Association, American Society of Echocardiography, American Society of Nuclear Cardiology, Society for Cardiovascular Angiography and Interventions, Society of Cardiovascular Computed Tomography, and Society of Thoracic Surgeons. J Am Coll Cardiol 69:2212–2241CrossRef Patel MR, Calhoon JH, Dehmer GJ, Grantham JA, Maddox TM, Maron DJ, Smith PK (2017) ACC/AATS/AHA/ASE/ASNC/SCAI/SCCT/STS 2017 appropriate use criteria for coronary revascularization in patients with stable ischemic heart disease: a report of the American College of Cardiology Appropriate Use Criteria Task Force, American Association for Thoracic Surgery, American Heart Association, American Society of Echocardiography, American Society of Nuclear Cardiology, Society for Cardiovascular Angiography and Interventions, Society of Cardiovascular Computed Tomography, and Society of Thoracic Surgeons. J Am Coll Cardiol 69:2212–2241CrossRef
5.
go back to reference Windecker S, Kolh P, Alfonso F, Collet JP, Cremer J, Falk V, Filippatos G, Hamm C, Head SJ, Jüni P, Kappetein AP, Kastrati A, Knuuti J, Landmesser U, Laufer G, Neumann FJ, Richter DJ, Schauerte P, Sousa Uva M, Stefanini GG, Taggart DP, Torracca L, Valgimigli M, Wijns W, Witkowski A (2014) 2014 ESC/EACTS guidelines on myocardial revascularization: The Task Force on myocardial revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS) developed with the special contribution of the European Association of Percutaneous Cardiovascular Interventions (EAPCI). Eur Heart J 35:2541–2619CrossRef Windecker S, Kolh P, Alfonso F, Collet JP, Cremer J, Falk V, Filippatos G, Hamm C, Head SJ, Jüni P, Kappetein AP, Kastrati A, Knuuti J, Landmesser U, Laufer G, Neumann FJ, Richter DJ, Schauerte P, Sousa Uva M, Stefanini GG, Taggart DP, Torracca L, Valgimigli M, Wijns W, Witkowski A (2014) 2014 ESC/EACTS guidelines on myocardial revascularization: The Task Force on myocardial revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS) developed with the special contribution of the European Association of Percutaneous Cardiovascular Interventions (EAPCI). Eur Heart J 35:2541–2619CrossRef
6.
go back to reference Hamaya R, Yonetsu T, Kanaji Y, Usui E, Hoshino M, Hada M, Kanno Y, Murai T, Lee T, Kakuta T (2019) Interrelationship in the prognostic efficacy of regional coronary flow reserve, fractional flow reserve, high-sensitivity cardiac troponin-I and NT-proBNP in patients with stable coronary artery disease. Heart Vessels 34(3):410–418CrossRef Hamaya R, Yonetsu T, Kanaji Y, Usui E, Hoshino M, Hada M, Kanno Y, Murai T, Lee T, Kakuta T (2019) Interrelationship in the prognostic efficacy of regional coronary flow reserve, fractional flow reserve, high-sensitivity cardiac troponin-I and NT-proBNP in patients with stable coronary artery disease. Heart Vessels 34(3):410–418CrossRef
7.
go back to reference Ferrante G, Rao SV, Jüni P, Da Costa BR, Reimers B, Condorelli G, Anzuini A, Jolly SS, Bertrand OF, Krucoff MW, Windecker S, Valgimigli M (2016) Radial versus femoral access for coronary interventions across the entire spectrum of patients with coronary artery disease: a meta-analysis of randomized trials. JACC Cardiovasc Interv 9:1419–1434CrossRef Ferrante G, Rao SV, Jüni P, Da Costa BR, Reimers B, Condorelli G, Anzuini A, Jolly SS, Bertrand OF, Krucoff MW, Windecker S, Valgimigli M (2016) Radial versus femoral access for coronary interventions across the entire spectrum of patients with coronary artery disease: a meta-analysis of randomized trials. JACC Cardiovasc Interv 9:1419–1434CrossRef
8.
go back to reference Valgimigli M, Gagnor A, Calabró P, Frigoli E, Leonardi S, Zaro T, Rubartelli P, Briguori C, Andò G, Repetto A, Limbruno U, Cortese B, Sganzerla P, Lupi A, Galli M, Colangelo S, Ierna S, Ausiello A, Presbitero P, Sardella G, Varbella F, Esposito G, Santarelli A, Tresoldi S, Nazzaro M, Zingarelli A, de Cesare N, Rigattieri S, Tosi P, Palmieri C, Brugaletta S, Rao SV, Heg D, Rothenbühler M, Vranckx P, Jüni P, MATRIX Investigators (2015) Radial versus femoral access in patients with acute coronary syndromes undergoing invasive management: a randomised multicentre trial. Lancet 385:2465–2476CrossRef Valgimigli M, Gagnor A, Calabró P, Frigoli E, Leonardi S, Zaro T, Rubartelli P, Briguori C, Andò G, Repetto A, Limbruno U, Cortese B, Sganzerla P, Lupi A, Galli M, Colangelo S, Ierna S, Ausiello A, Presbitero P, Sardella G, Varbella F, Esposito G, Santarelli A, Tresoldi S, Nazzaro M, Zingarelli A, de Cesare N, Rigattieri S, Tosi P, Palmieri C, Brugaletta S, Rao SV, Heg D, Rothenbühler M, Vranckx P, Jüni P, MATRIX Investigators (2015) Radial versus femoral access in patients with acute coronary syndromes undergoing invasive management: a randomised multicentre trial. Lancet 385:2465–2476CrossRef
9.
go back to reference Neumann FJ, Sousa-Uva M, Ahlsson A, Alfonso F, Banning AP, Benedetto U, Byrne RA, Collet JP, Falk V, Head SJ, Jüni P, Kastrati A, Koller A, Kristensen SD, Niebauer J, Richter DJ, Seferovic PM, Sibbing D, Stefanini GG, Windecker S, Yadav R, Zembala MO, ESC Scientific Document Group (2019) 2018 ESC/EACTS guidelines on myocardial revascularization. Eur Heart J 40:87–165CrossRef Neumann FJ, Sousa-Uva M, Ahlsson A, Alfonso F, Banning AP, Benedetto U, Byrne RA, Collet JP, Falk V, Head SJ, Jüni P, Kastrati A, Koller A, Kristensen SD, Niebauer J, Richter DJ, Seferovic PM, Sibbing D, Stefanini GG, Windecker S, Yadav R, Zembala MO, ESC Scientific Document Group (2019) 2018 ESC/EACTS guidelines on myocardial revascularization. Eur Heart J 40:87–165CrossRef
10.
go back to reference Kuno T, Hirano K, Abe T, Imaeda S, Hashimoto K, Ryuzaki T, Yokokura S, Saito T, Yamazaki H, Tabei R, Kodaira M, Numasawa Y (2019) Trans-radial percutaneous coronary intervention for patients with severe chronic renal insufficiency and/or on dialysis. Heart Vessels 34:1412–1419CrossRef Kuno T, Hirano K, Abe T, Imaeda S, Hashimoto K, Ryuzaki T, Yokokura S, Saito T, Yamazaki H, Tabei R, Kodaira M, Numasawa Y (2019) Trans-radial percutaneous coronary intervention for patients with severe chronic renal insufficiency and/or on dialysis. Heart Vessels 34:1412–1419CrossRef
11.
go back to reference Kawase Y, Matsuo H, Akasaka T, Shiono Y, Tanaka N, Amano T, Kozuma K, Nakamura M, Yokoi H, Kobayashi Y, Ikari Y (2019) Clinical use of physiological lesion assessment using pressure guidewires: an expert consensus document of the Japanese Association of Cardiovascular Intervention and Therapeutics. Cardiovasc Interv Ther 34:85–96CrossRef Kawase Y, Matsuo H, Akasaka T, Shiono Y, Tanaka N, Amano T, Kozuma K, Nakamura M, Yokoi H, Kobayashi Y, Ikari Y (2019) Clinical use of physiological lesion assessment using pressure guidewires: an expert consensus document of the Japanese Association of Cardiovascular Intervention and Therapeutics. Cardiovasc Interv Ther 34:85–96CrossRef
12.
go back to reference Pijls NH, Kern MJ, Yock PG, De Bruyne B (2000) Practice and potential pitfalls of coronary pressure measurement. Catheter Cardiovasc Interv 49:1–16CrossRef Pijls NH, Kern MJ, Yock PG, De Bruyne B (2000) Practice and potential pitfalls of coronary pressure measurement. Catheter Cardiovasc Interv 49:1–16CrossRef
13.
go back to reference Puymirat É, Muller O, Sharif F, Dupouy P, Cuisset T, de Bruyne B, Gilard M (2010) Fractional flow reserve: concepts, applications and use in France in 2010. Arch Cardiovasc Dis 103:615–622CrossRef Puymirat É, Muller O, Sharif F, Dupouy P, Cuisset T, de Bruyne B, Gilard M (2010) Fractional flow reserve: concepts, applications and use in France in 2010. Arch Cardiovasc Dis 103:615–622CrossRef
14.
go back to reference Matsumura M, Johnson NP, Fearon WF, Mintz GS, Stone GW, Oldroyd KG, De Bruyne B, Pijls NHJ, Maehara A, Jeremias A (2017) Accuracy of fractional flow reserve measurements in clinical practice: observations from a core laboratory analysis. JACC Cardiovasc Interv 10:1392–1401CrossRef Matsumura M, Johnson NP, Fearon WF, Mintz GS, Stone GW, Oldroyd KG, De Bruyne B, Pijls NHJ, Maehara A, Jeremias A (2017) Accuracy of fractional flow reserve measurements in clinical practice: observations from a core laboratory analysis. JACC Cardiovasc Interv 10:1392–1401CrossRef
15.
go back to reference Moriyama N, Yamanaka F, Shishido K, Tobita K, Yokota S, Hayashi T, Koike T, Miyashita H, Yokoyama H, Nishimoto T, Takada T, Ochiai T, Mizuno S, Tanaka Y, Murakami M, Takahashi S, Saito S (2018) The COFFEE Trial (COmparison of Fractional Flow Reserve Measurements through 4 French versus 6 French Diagnostic Catheter). JACC Cardiovasc Interv 11:414–416CrossRef Moriyama N, Yamanaka F, Shishido K, Tobita K, Yokota S, Hayashi T, Koike T, Miyashita H, Yokoyama H, Nishimoto T, Takada T, Ochiai T, Mizuno S, Tanaka Y, Murakami M, Takahashi S, Saito S (2018) The COFFEE Trial (COmparison of Fractional Flow Reserve Measurements through 4 French versus 6 French Diagnostic Catheter). JACC Cardiovasc Interv 11:414–416CrossRef
16.
go back to reference Legalery P, Seronde MF, Meneveau N, Schiele F, Bassand JP (2003) Measuring pressure-derived fractional flow reserve through four French diagnostic catheters. Am J Cardiol 91:1075–1078CrossRef Legalery P, Seronde MF, Meneveau N, Schiele F, Bassand JP (2003) Measuring pressure-derived fractional flow reserve through four French diagnostic catheters. Am J Cardiol 91:1075–1078CrossRef
17.
go back to reference Kato D, Takashima H, Waseda K, Kurita A, Kuroda Y, Kosaka T, Kuhara Y, Ando H, Maeda K, Kumagai S, Sakurai S, Suzuki A, Toda Y, Watanabe A, Sato S, Fujimoto M, Mizuno T, Amano T (2015) Feasibility and safety of intracoronary nicorandil infusion as a novel hyperemic agent for fractional flow reserve measurements. Heart Vessels 30:477–548CrossRef Kato D, Takashima H, Waseda K, Kurita A, Kuroda Y, Kosaka T, Kuhara Y, Ando H, Maeda K, Kumagai S, Sakurai S, Suzuki A, Toda Y, Watanabe A, Sato S, Fujimoto M, Mizuno T, Amano T (2015) Feasibility and safety of intracoronary nicorandil infusion as a novel hyperemic agent for fractional flow reserve measurements. Heart Vessels 30:477–548CrossRef
18.
go back to reference Jeremias A, Kirtane AJ, Stone GW (2017) A test in context: fractional flow reserve: accuracy, prognostic implications, and limitations. J Am Coll Cardiol 69:2748–2758CrossRef Jeremias A, Kirtane AJ, Stone GW (2017) A test in context: fractional flow reserve: accuracy, prognostic implications, and limitations. J Am Coll Cardiol 69:2748–2758CrossRef
19.
go back to reference McGhee BH, Bridges EJ (2002) Monitoring arterial blood pressure: what you may not know. Crit Care Nurse 22:60–64CrossRef McGhee BH, Bridges EJ (2002) Monitoring arterial blood pressure: what you may not know. Crit Care Nurse 22:60–64CrossRef
Metadata
Title
Functional assessment of intermediate coronary artery stenosis with 4-Fr catheters
Authors
Kazutaka Nogi
Tsunenari Soeda
Masahiko Hara
Hajime Iwama
Nozomi Toyokawa
Satoshi Sakai
Hiroki Yano
Atsushi Iwai
Yukihiro Hashimoto
Hajime Fujimoto
Megumi Suzuki
Takehito Nakai
Naofumi Doi
Yoshihiko Saito
Publication date
01-05-2021
Publisher
Springer Japan
Published in
Heart and Vessels / Issue 5/2021
Print ISSN: 0910-8327
Electronic ISSN: 1615-2573
DOI
https://doi.org/10.1007/s00380-020-01746-2

Other articles of this Issue 5/2021

Heart and Vessels 5/2021 Go to the issue